HIV protease resistance mutations in patients receiving second-line antiretroviral therapy in Libreville, Gabon

HIV protease resistance mutations in patients receiving second-line antiretroviral therapy in Libreville, Gabon

Abstract Introduction In 2022, the WHO reported that 29.8 million people around the world were living with HIV (PLHIV) and receiving antiretroviral treatment (ART), including 25‌ 375 people in Gabon (54% of all those living with HIV in the country). The literature reports a frequency of therapeutic...

Full description

Bibliographic Details
Main Authors: Guy Francis Nzengui-Nzengui, Gaël Mourembou, Hervé M’boyis-Kamdem, Ayawa Claudine Kombila-Koumavor, Angélique Ndjoyi-Mbiguino
Format: Article
Language:English
Published: BMC 2024-03-01
Series:BMC Infectious Diseases
Subjects:
HIV
Protease
Resistance mutations
Antiretroviral
Gabon
Online Access:https://doi.org/10.1186/s12879-024-09156-9

Internet

https://doi.org/10.1186/s12879-024-09156-9

Similar Items